{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:28:41Z","timestamp":1740144521864,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 81570305","81600265"],"award-info":[{"award-number":["NSFC 81570305","81600265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute thrombotic thrombocytopenic purpura (TTP) is an aggressive thrombotic microangiopathy that if not treated, can have a 90% mortality rate. Timely, extensive plasma exchange (PEX) has been indicated to reduce the mortality rate to &lt;\u200910%, but its side effects are not well-known. We present here a case of a patient presented with Comb (+) TTP and developed catheter-associated deep vein thrombosis (DVT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 27-year-young man presented with persistent thrombocytopenia and Coombs positive anemia was firstly diagnosed with Evans syndrome. However, he was refractory to a methylprednisolone pulse therapy with a combination of platelet transfusion and eventually developed microangiopathy of central nerve system. Several pathological manifestations of the disease were prevented by PEX. The immediate start of PEX (1500\u00a0mL\/d) induced a complete remission of acquired TTP and disappearance of neurological signs and symptoms. However, external iliac and femoro-popliteal venous thrombosis was diagnosed subsequently, inferior vena cava filter (IVC) filter was immediately implanted accompanied with anticoagulation therapy. Meanwhile, PEX session was sustained as well as oral anticoagulant (rivaroxaban). 14\u00a0days later, the patient got full recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Catheter-related DVT under the setting of TTP should be cautious. It is necessary to start anticoagulation and antiplatelet therapy for thrombosis early, especially in such cases when PLT count\u2009&gt;\u200950\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01789-8","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T09:03:29Z","timestamp":1647853409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complete recovery of deep venous thrombosis from Coombs (+) thrombotic thrombocytopenic purpura: case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Mi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371:654\u201366.","journal-title":"N Engl J Med"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-0031-1300951","volume":"38","author":"K Chapman","year":"2012","unstructured":"Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost. 2012;38:47\u201354.","journal-title":"Semin Thromb Hemost"},{"key":"1789_CR3","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/bloodadvances.2017012351","volume":"1","author":"JN George","year":"2017","unstructured":"George JN, Sandler SA, Stankiewicz J. Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah\u2019s Witness experience. Blood Adv. 2017;1:2161\u20135.","journal-title":"Blood Adv"},{"key":"1789_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ. British Committee for Standards in H: guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158:323\u201335.","journal-title":"Br J Haematol"},{"key":"1789_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","volume":"40","author":"A Froissart","year":"2012","unstructured":"Froissart A, Buffet M, Veyradier A, Poullin P, Provot F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, et al. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Crit Care Med. 2012;40:104\u201311.","journal-title":"Crit Care Med"},{"key":"1789_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fmed.2017.00089","volume":"4","author":"D Dimopoulou","year":"2017","unstructured":"Dimopoulou D, Dimosiari A, Mandala E, Dimitroulas T, Garyfallos A. Autoimmune thrombotic thrombocytopenic purpura: two rare cases associated with juvenile idiopathic arthritis and multiple sclerosis. Front Med (Lausanne). 2017;4:89.","journal-title":"Front Med (Lausanne)"},{"issue":"1156","key":"1789_CR7","first-page":"e1153","volume":"32","author":"C Zhang","year":"2014","unstructured":"Zhang C, Chen XH, Zhang X. Quick development and sudden death: evans syndrome followed by thrombotic thrombocytopenic purpura. Am J Emerg Med. 2014;32(1156):e1153\u20134.","journal-title":"Am J Emerg Med"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","volume":"1","author":"EE Page","year":"2017","unstructured":"Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017;1:590\u2013600.","journal-title":"Blood Adv"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1537-2995.2006.00687.x","volume":"46","author":"MA Howard","year":"2006","unstructured":"Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006;46:154\u20136.","journal-title":"Transfusion"},{"key":"1789_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1536\/ihj.16-100","volume":"57","author":"T Oshima","year":"2016","unstructured":"Oshima T, Ikutomi M, Shinohara H, Ishiwata J, Fukino K, Amaki T, Nakamura F. Acute myocardial infarction caused by thrombotic microangiopathy complicated with myelodysplastic syndrome. Int Heart J. 2016;57:634\u20136.","journal-title":"Int Heart J"},{"key":"1789_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMra011883","volume":"348","author":"DC McGee","year":"2003","unstructured":"McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123\u201333.","journal-title":"N Engl J Med"},{"key":"1789_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.thromres.2017.06.005","volume":"156","author":"A Rottenstreich","year":"2017","unstructured":"Rottenstreich A, Kalish Y, Tvito A, Hauschner H, Arad A. Acquired thrombotic thrombocytopenic purpura in pregnancy: the role of placental and breast-milk mediated transfer of ADAMTS13-autoantibodies. Thromb Res. 2017;156:80\u20131.","journal-title":"Thromb Res"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"e6547","DOI":"10.1097\/MD.0000000000006547","volume":"96","author":"H Nakao","year":"2017","unstructured":"Nakao H, Ishiguro A, Ikoma N, Nishi K, Su C, Nakadate H, Kubota M, Hayakawa M, Matsumoto M. Acquired idiopathic thrombotic thrombocytopenic purpura successfully treated with intravenous immunoglobulin and glucocorticoid: a case report. Medicine (Baltimore). 2017;96:e6547.","journal-title":"Medicine (Baltimore)"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1182\/blood-2018-04-840090","volume":"132","author":"M Jestin","year":"2018","unstructured":"Jestin M, Benhamou Y, Schelpe A-S, Roose E, Galicier L,Girault S, et al. Rituximab prevents long-term relapses in TTP. Blood. 2018;132:2210.","journal-title":"Blood"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1097\/MJT.0000000000000808","volume":"26","author":"S Thumma","year":"2019","unstructured":"Thumma S, Idrees S, Phuyal P, Manchala V, Mattana J. When the standard treatment fails: rituximab therapy for refractory TTP. Am J Ther. 2019;26:e552\u20133.","journal-title":"Am J Ther"},{"key":"1789_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1505533","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knobl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, et al. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2016;374:511\u201322.","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01789-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T09:05:50Z","timestamp":1647853550000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01789-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01789-8","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study has received Ethics approval of Qianfoshan Hospital and patients\u2019 informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Our study has received all authors\u2019 consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}